469 results on '"Selinger, Christian P."'
Search Results
2. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
3. Episome partitioning and symmetric cell divisions: quantifying the role of random events in the persistence of HPV infections
4. Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
5. The development of a minimum dataset for MRI reporting of anorectal fistula: a multi-disciplinary, expert consensus process
6. Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study.
7. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
8. IBD in women of reproductive age: where do novel therapies fit in?
9. Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians
10. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
11. Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection
12. Introduction to the DDS Mini‑Issue: “Inflammatory Bowel Disease and Pregnancy”
13. Using the PIDA on Your PDA: Providing Personalized Education and Decision Support for Women with IBD of Childbearing Age
14. Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
15. The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice
16. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism
17. Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review
18. Editorial: Exploring the interplay between clinical and non-clinical outcomes for children and adults with inflammatory bowel disease
19. The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.
20. Stigmatisation and resilience in inflammatory bowel disease
21. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
22. Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis
23. A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
24. Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates
25. The future of a partially effective HIV vaccine: assessing limitations at the population level
26. Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy
27. Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review.
28. Palliative Treatment of Dysphagia
29. Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of <scp>UK IBD</scp> units and patients
30. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding
31. Anal high-risk human papillomavirus infection, squamous intraepithelial lesions and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis
32. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease
33. The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios
34. Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study
35. British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance.
36. Establishing key performance indicators for inflammatory bowel disease in the UK.
37. Planning to conceive within a year is associated with better pregnancy-specific disease-related patient knowledge and better medication adherence in women of childbearing age with inflammatory bowel disease.
38. Obstetric Considerations in Pregnant Women with Crohn’s Disease
39. Systematic review with network meta‐analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease
40. Characteristics and Effect of Anxiety and Depression Trajectories in Inflammatory Bowel Disease
41. Letter: Addressing opioid exposure and associated harms in patients with IBD.
42. Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous Preparations
43. British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance
44. Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease—authors' reply
45. Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease
46. Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
47. Factors Associated with Family Planning Status and Voluntary Childlessness in Women of Childbearing Age with Inflammatory Bowel Diseases.
48. Safety and tolerability of spesolimab in patients with ulcerative colitis
49. P60 Sources of excess steroid prescriptions and associated adverse outcomes in patients with IBD
50. Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.